Research map: Juvenile Parkinson's disease: Symptom burden and treatment challenges
Back to the article
Papers in this map
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
· Michael J. Soileau · 2022 · 236 citations · Cited by this paper
Celebrating the legacy of two decades of Parkinson's disease research in South Africa
· 2026 · Related
Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment
· Stéphane Prange · 2022 · 167 citations · Cited by this paper
Practical approaches to inclusive recruitment practices in Parkinson's disease research
· 2026 · Related
Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice
· Fang Ba · 2014 · 160 citations · Cited by this paper
Structural biology of alpha-synuclein amyloid filaments: Implications in synucleinopathies
· 2026 · Related
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
· Nicki Niemann · 2019 · 109 citations · Cited by this paper
Clinical GDNF delivery methods for Parkinson's disease
· 2026 · Related
The levodopa wearing-off phenomenon in Parkinson’s disease: pharmacokinetic considerations
· Fabrizio Stocchi · 2006 · 108 citations · Cited by this paper
Differential effects of levodopa on social cognition in people with Parkinson's disease
· 2026 · Related
Levodopa-induced dyskinesia in Parkinson disease
· Pierpaolo Turcano · 2018 · 107 citations · Cited by this paper
Greater burden of Alzheimer's Co-pathology in women with Parkinson's disease dementia
· 2026 · Related
Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease
· Massimo Filippi · 2020 · 81 citations · Cited by this paper
Parkinson's disease and the concept of resilience, cognitive, and motor reserve
· 2026 · Related
Diagnostic considerations in juvenile parkinsonism
· Dominic C. Paviour · 2003 · 66 citations · Cited by this paper
Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies
· 2026 · Related
Rare Causes of Dystonia Parkinsonism
· Susanne A. Schneider · 2010 · 44 citations · Cited by this paper
Digital profiling of dysarthria in late- and early-onset Parkinson's disease
· 2026 · Related
Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence
· Hugo Morales‐Briceño · 2019 · 42 citations · Cited by this paper
Crowdsourcing and machine learning contests in Parkinson's disease research - when do they work?
· 2026 · Related
The mutation spectrum of Parkinson‐disease ‐related genes in early‐onset Parkinson's disease in ethnic Chinese
· Yongping Chen · 2022 · 32 citations · Cited by this paper
Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study
· Lanfranco De Carolis · 2023 · 21 citations · Cited by this paper
Impact of Non-Motor Symptoms on Quality of Life in Patients with Early-Onset Parkinson’s Disease
· Ameya Patwardhan · 2024 · 17 citations · Cited by this paper
40-Year Incidence of Early-Onset Parkinson’s Disease in Southeast Minnesota
· Emanuele Camerucci · 2023 · 11 citations · Cited by this paper
Autonomic Dysfunction and Risk of Mortality in Early‐Onset Parkinson's Disease
· Capucine Piat · 2025 · 3 citations · Cited by this paper
Source: OpenAlex (CC0)